In pancreatic cancer, NSD3 silencing resulted in inhibition of S6K1 phosphorylation, indicating that in the absence of the NSD3 oncoprotein mTOR was not activated [48]. This evidence concerns the gene NSD3 and pancreatic neoplasm.